S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Kuehn Law Launches Inquiry into TG Therapeutics Leadership

Shareholders of TG Therapeutics, Inc. are under scrutiny as New York-based Kuehn Law, PLLC, investigates potential breaches of fiduciary duty by the company’s officers and directors. The inquiry centers on allegations of self-dealing, opening a window for long-term investors to pursue legal remedies or demand corporate governance reforms.

Kuehn Law Launches Inquiry into TG Therapeutics Leadership
Photo: Bio & News

Justin Kuehn, the lead attorney on the investigation, is calling for long-term TGTX stockholders to come forward regarding their holdings. The firm frames this action as a move to uphold financial market integrity, offering free consultations to those who believe the board’s conduct has compromised shareholder value. Kuehn Law has stated it will cover all litigation costs for participating investors, emphasizing that time may be limited for stakeholders to assert their rights in this matter. While the firm highlights the potential for damages, they note that previous legal outcomes do not serve as a guarantee for future results.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!